Fabry Disease Clinical Trials

A listing of Fabry Disease medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

 

Alabama

UPDATED

Birmingham Alabama 35205

A clinical research study of GZ402671 for the treatment of Fabry's Disease

California

UPDATED

Orange California 92868

A clinical research study of migalastat HCl for the treatment of Fabry Disease

Los Angeles California 90048

A clinical trial seeking patients for a research study for the treatment of Fabry Disease

Sacramento California 95817

Patients are needed to participate in a clinical research study evaluating PRX-102 for the treatment of Fabry Disease

Georgia

UPDATED

Atlanta Georgia 30322

A clinical research study of GZ402671 for the treatment of Fabry's Disease

Atlanta Georgia 30322

Patients are needed to participate in a clinical research study evaluating PRX-102 for the treatment of Fabry Disease

Decatur Georgia 30033

A clinical trial seeking patients for a research study for the treatment of Fabry Disease

Decatur Georgia 30033

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Decatur Georgia 30033

Patients are needed to participate in a clinical research study of Iohexol to evaluate Fabry Disease

Illinois

Chicago Illinois 60611

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Iowa

Iowa City Iowa 52242

Patients are needed to participate in a clinical research study evaluating PRX-102 for the treatment of Fabry Disease

Kansas

Kansas City Kansas 66160

A clinical trial seeking patients for a research study for the treatment of Fabry Disease

Kansas City Kansas 66160

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Kansas City Kansas 66160

Patients are needed to participate in a clinical research study evaluating PRX-102 for the treatment of Fabry Disease

Maryland

Baltimore Maryland 21205

Patients are needed to participate in a clinical research study evaluating PRX-102 for the treatment of Fabry Disease

Massachusetts

Boston Massachusetts 02114

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Cambridge Massachusetts

Patients are needed to participate in a clinical research study evaluating agalsidase beta for the treatment of Fabry Disease

Cambridge Massachusetts 02142

Patients are needed to participate in a clinical research study to evaluate Fabry Disease

Michigan

Grand Rapids Michigan 49525

A clinical trial seeking patients for a research study for the treatment of Fabry Disease

Grand Rapids Michigan 49525

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

New York

New York New York 10016

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

North Carolina

Durham North Carolina 27710

Patients are needed to participate in a clinical research study evaluating PRX-102 for the treatment of Fabry Disease

Ohio

UPDATED

Cincinnati Ohio 45229

A clinical research study of GZ402671 for the treatment of Fabry's Disease

Cincinnati Ohio 45229-3039

Patients are needed to participate in a clinical research study of Iohexol to evaluate Fabry Disease

Columbus Ohio 43212

A clinical trial seeking patients for a research study for the treatment of Fabry Disease

Oregon

Portland Oregon 97239

A clinical trial seeking patients for a research study for the treatment of Fabry Disease

Portland Oregon 97239

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Pennsylvania

Pittsburgh Pennsylvania 15224

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Pittsburgh Pennsylvania 15224

Patients are needed to participate in a clinical research study evaluating PRX-102 for the treatment of Fabry Disease

Texas

Baylor Research Institute
Dallas Texas 75204

A Phase 1/2, Open Label, Dose Ranging Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Exploratory Efficacy Parameters of PRX-102 Administered by Intravenous Infusion Every 2 Weeks for 12 Weeks to Adult Fabry Patients

View More ▼

Dallas Texas 75226

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Dallas Texas 75226

Patients are needed to participate in a clinical research study evaluating PRX-102 for the treatment of Fabry Disease

Virginia

UPDATED

Fairfax Virginia 22030

A clinical research study of GZ402671 for the treatment of Fabry's Disease

Fairfax Virginia 22030

A clinical trial seeking patients for a research study for the treatment of Fabry Disease

Fairfax Virginia 22030

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Fairfax Virginia 22030

Patients are needed to participate in a clinical research study evaluating PRX-102 for the treatment of Fabry Disease

Fairfax Virginia 22030

Patients are needed to participate in a clinical research study of Iohexol to evaluate Fabry Disease

Washington

Seattle Washington 98195-6320

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Wisconsin

Milwaukee Wisconsin 532261

Patients are needed to participate in a clinical research study of Iohexol to evaluate Fabry Disease

Australia

UPDATED

Parkville Victoria 3050

A clinical research study of migalastat HCl for the treatment of Fabry Disease

Czech Republic

UPDATED

Praha 2 12808

A clinical research study of GZ402671 for the treatment of Fabry's Disease

Poland

UPDATED

Warszawa 04-730

A clinical research study of GZ402671 for the treatment of Fabry's Disease

Russian Federation

UPDATED

Moscow 119991

A clinical research study of GZ402671 for the treatment of Fabry's Disease

UPDATED

Moscow 125167

A clinical research study of GZ402671 for the treatment of Fabry's Disease

United Kingdom

UPDATED

Cambridge CB2 OQQ

A clinical research study of GZ402671 for the treatment of Fabry's Disease

Argentina

Pilar B1629ODT

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Australia

North Adelaide 5006

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Parkville Victoria 3050

Patients are needed to participate in a clinical research study evaluating migalastat HCl 150mg for the treatment of Fabry Disease

Victoria 3050

Patients are needed to participate in a clinical research study evaluating PRX-102 for the treatment of Fabry Disease

Austria

Graz A-8036

A clinical trial to evaluate treatments using No intervention for patients with Fabry Disease or Cerebrovascular Accident